MRSN
USDMersana Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$9.065
High
$9.065
Low
$8.000
Volume
0.03M
Company Fundamentals
Market Cap
40.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.07M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Truist Securities Maintains Buy on Mersana Therapeutics, Adjusts Price Target To $36 from $250
Truist Securities analyst Asthika Goonewardene maintains Mersana Therapeutics with a Buy, Adjusts Target to $36 from $250
Guggenheim Maintains Buy on Mersana Therapeutics, Lowers Price Target to $30
Guggenheim analyst Michael Schmidt maintains Mersana Therapeutics with a Buy and lowers the price target from $125 to $30.
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
More than 45 patients enrolled in Emi-Le Phase 1 dose expansion cohorts in post-topoisomerase-1 inhibitor ADC (post-topo-1) triple-negative breast cancer (TNBC)Plan to report initial clinical data from Emi-Le expansion
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers
Related Stocks
SBH
Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
CRF
Cornerstone Total Return Fund Inc. (The)
AFGD
American Financial Group Inc. 5.625% Subordinated Debentures due 2060
VRM
Vroom Inc.
BDC
Belden Inc
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.